Venetoclax With Decitabine vs Intensive Chemotherapy in AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax With Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified by Risk of Treatment-Related Mortality
Am. J. Hematol 2020 Dec 02;[EPub Ahead of Print], A Maiti, W Qiao, K Sasaki, F Ravandi, TM Kadia, EJ Jabbour, NG Daver, G Borthakur, G Garcia-Manero, SA Pierce, KS Montalbano, N Pemmaraju, K Naqvi, M Ohanian, NJ Short, Y Alvarado, K Takahashi, M Yilmaz, N Jain, SM Kornblau, M Andreeff, P Bose, A Ferrajoli, GC Issa, L Masarova, PA Thompson, CR Rausch, J Ning, HM Kantarjian, CD DiNardo, MY KonoplevaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.